by Li-Anne Rowswell Mufson | Mar 10, 2024 | Compliance
If you have been watching this space or paying attention at all, you know that the Biotech and Pharma industries are constantly innovating, pushing boundaries, and developing life-saving treatments. But to paraphrase Spiderman, with great innovation comes great...
by Li-Anne Rowswell Mufson | Feb 1, 2024 | AI in Life Sciences
We’ve been on Hiatus for a few months, generally having a “Make-Over.” We have been doing some fixing up and growing within our company, looking at the blog as well, and at last, we are back! We now have a title for this Blog Space. We are calling...
by Li-Anne Rowswell Mufson | Jul 10, 2023 | data management services
At Metis Consulting Services, we are thrilled to announce that This Summer, 2023, is the launch of our Data Management division. The increasing focus on the importance of data in the pharmaceutical and biotech industry is driving a need. It is crucial to have robust...
by Li-Anne Rowswell Mufson | Jun 1, 2023 | Pharmacovigilance
Pharmacovigilance (PV) is the process of monitoring, detecting, assessing, and preventing adverse effects or other drug-related problems. It aims to ensure the safety and efficacy of drugs after they have been approved for use. While the primary objective of PV is to...
by Li-Anne Rowswell Mufson | Mar 23, 2023 | Uncategorized
RIC, REMS, and the REMarkable Dr. Frances Oldham Kelsey METIS’ CEO and Founder Michelleanne is finishing up with the SQA Conference and is headed to the REMSIndustry Consortium (RIC) to Convene on March 22nd and 23rd. The promised second half of our blog on REMS...
Recent Comments